Ribodex Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Ribodex General Information
Description
Developer of programmed-ribosome technology designed for needle-free hair follicle regeneration. The company's platform uses patented Ribodex technology to guide ribosomes toward producing specific proteins and growth factors, including Keratin, FGF-7, and VEGF within hair follicle cells through transdermal sonic delivery rather than injections or blood extraction, enabling the medical spa, salon, and clinical hair restoration market to administer a needle-free hair regeneration treatment without depending on PRP procedures requiring blood extraction, injectable therapies, or topical products.
Contact Information
Website
www.ribo.hairCorporate Office
- Las Vegas, NV
- United States
Corporate Office
- Las Vegas, NV
- United States
Ribodex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | Completed | Generating Revenue |
Ribodex Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Borden Industries | Venture Capital | Minority |
Ribodex FAQs
-
Where is Ribodex headquartered?
Ribodex is headquartered in Las Vegas, NV.
-
What industry is Ribodex in?
Ribodex’s primary industry is Biotechnology.
-
Is Ribodex a private or public company?
Ribodex is a Private company.
-
What is Ribodex’s current revenue?
The current revenue for Ribodex is .
-
Who are Ribodex’s investors?
Borden Industries has invested in Ribodex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process